Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?



Rating:

Share or cite this content

Citations should be made in the following way:
T. Berghmans (Brussels, Belgium). Current clinical trials. ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?

Member's Comments

No comment yet.

Related content which might interest you: Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Clinical trials based on biomarkers Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 LAM clinical trials and the state-of-the-art Source: International Congress 2014 – Advances in care for patients with lymphangioleiomyomatosis (LAM) Year: 2014 Clinical trials and outcome measures Source: School Course 2013 - Primary ciliary dyskinesia: sharing knowledge and experience across Europe Year: 2013 Publication rate and characteristics of industry-sponsored asthma clinical trials Source: Virtual Congress 2020 – How do different treatment strategies translate into costs Year: 2020 The future of translational lung cancer research: from classical randomised controlled trials to innovative platform trials Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018 Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial Source: Eur Respir J 2001; 18: Suppl. 33, 518s Year: 2001 Key role of patients in clinical trials Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research Year: 2013 Vaccines - early clinical trials Source: Virtual Congress 2020 – Management prevention Year: 2020 Clinical effectiveness of MDI-HFA-Modulite budesonide in the treatment of asthma – meta-analysis of randomised controlled trials Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006 Clinical trial landscape for M/XDR-TB: current evidence and future perspectives Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 Antiviral therapy – the evidence base and clinical trials Source: International Congress 2015 – PG11 Emerging infectious diseases and pandemic planning Year: 2015 Evidence of efficacy for sequential combination therapy in recent randomized controlled trials (RCTs) Source: International Congress 2014 – Combination therapy in pulmonary arterial hypertension (PAH): the evidence grows Year: 2014 Applicability of randomized controlled trials (RCTs) results to real-life patients in COPD Source: International Congress 2017 – Management of COPD Year: 2017 Effectiveness of the tromboembolic venous disease treatments estimated through clinical trials vs. observational studies Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment Year: 2019 A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults Source: Eur Respir Rev, 28 (151) 180108; 10.1183/16000617.0108-2018 Year: 2019 Clinical trials design in the age of precision medicine Source: ERS webinar 2020: Clinical trials design in the age of precision medicine Year: 2020